Eduardo Beruff, CEO & President, eviti, Inc. “Traditionally clinical trials has been seen as a last-ditch heroic effort. Unfortunately when they are viewed that way, most patients don’t qualify for trials because of their previous treatment history. So we believe that the eviti platform clinicians will be able to see appropriate clinical trials at the moment of prescribing of care. Recently we have acquired the nation’s largest database and search engine for cancer clinical trials – Trial Check. This is ideal because of our philosophy regarding cancer clinical trials. We consider them to be a treatment option that should be offered with other treatment options from the get go.”
Robert Comis, MD, Chairman, eviti, Inc. “Trial Check was developed because there was a need for a simple, rapid way to find clinical trials anywhere in the country. So over the years we developed Trial Check with that in mind. It needed to be simple, it needed to be scalable, and it needed to be oriented toward the patients and the physicians. So the key for us was to find a way to put Trial Check in the mainstream. And the mainstream is eviti.”
Larissa Tis, Senior Director of Strategic Partnerships, eviti, Inc.. “Trial Check is unique in the sense that it is the only clinical trials database that has standardized eligibility for the entire set of cancer clinical trials. You can’t go to any other website to get that information, or database. Trial Check is structured around eligibility components for cancer clinical trials around prior treatment history, stage of disease, performance status, and all of that information has been tamed by a team of oncology clinicians and it may or may not be surprising, but we have somewhere between 50 and 100 new clinical trials in the system every week. So when you combine that with the fact that eviti has the broadest and most detailed approved treatment regimens, then it’s a home run. eviti, as far as I know is the only system out there that brings clinical trials and evidence based medicine together in one clinical decision support tool.”
